Cargando…

Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial

BACKGROUND: Preoperative supplementation with immunonutrients, including arginine and n-3 fatty acids, has been shown in a number of systematic reviews to reduce infectious complications in patients who have undergone gastrointestinal surgery. Limited information, however, is available on the benefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Kylie, Zhang, Han-Guang, Gillanders, Lyn K, Bartlett, Adam SJR, Fisk, Helena L, Calder, Philip C, Swan, Peter J, Plank, Lindsay D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447421/
https://www.ncbi.nlm.nih.gov/pubmed/30967908
http://dx.doi.org/10.4254/wjh.v11.i3.305
_version_ 1783408501410758656
author Russell, Kylie
Zhang, Han-Guang
Gillanders, Lyn K
Bartlett, Adam SJR
Fisk, Helena L
Calder, Philip C
Swan, Peter J
Plank, Lindsay D
author_facet Russell, Kylie
Zhang, Han-Guang
Gillanders, Lyn K
Bartlett, Adam SJR
Fisk, Helena L
Calder, Philip C
Swan, Peter J
Plank, Lindsay D
author_sort Russell, Kylie
collection PubMed
description BACKGROUND: Preoperative supplementation with immunonutrients, including arginine and n-3 fatty acids, has been shown in a number of systematic reviews to reduce infectious complications in patients who have undergone gastrointestinal surgery. Limited information, however, is available on the benefits of nutritional supplementation enriched with arginine and n-3 fatty acids in patients undergoing liver resection. AIM: To evaluate the effects of preoperative nutritional supplementation enriched with arginine and n-3 fatty acids on inflammatory and immunologic markers and clinical outcome in patients undergoing liver resection. METHODS: Thirty-four patients undergoing liver resection were randomized to either five days of preoperative Impact(®) [1020 kcal/d, immunonutrition (IMN) group], or standard care [no supplementation, standard care (STD) group]. Nutritional status was measured at study entry by subjective global assessment (SGA). Functional assessments (grip strength, fatigue and performance status) were carried out at study entry, on the day prior to surgery, and on postoperative day (POD) 7 and 30. Inflammatory and immune markers were measured at study entry, on the day prior to surgery, and POD 1, 3, 5, 7, 10 and 30. Postoperative complications were recorded prospectively until POD30. RESULTS: A total of 32 patients (17 IMN and 15 STD) were analysed. All except four patients were SGA class A. The plasma ratio of (eicosapentaenoic acid plus docosahexaenoic acid) to arachidonic acid was higher in IMN patients on the day prior to surgery and POD 1, 3, 5 and 7 (P < 0.05). Plasma interleukin (IL)-6 concentrations were elevated in the IMN group (P = 0.017 for POD7). No treatment effect was detected for functional measures, immune response (white cell count and total lymphocytes) or markers of inflammation (C-reactive protein, tumour necrosis factor-α, IL-8, IL-10). There were 10 patients with infectious complications in the IMN group and 4 in the STD group (P = 0.087). Median hospital stay was 9 (range 4–49) d in the IMN group and 8 (3-34) d in the STD group (P = 0.476). CONCLUSION: In well-nourished patients undergoing elective liver resection, this study failed to show any benefit of preoperative immunonutrition.
format Online
Article
Text
id pubmed-6447421
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-64474212019-04-09 Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial Russell, Kylie Zhang, Han-Guang Gillanders, Lyn K Bartlett, Adam SJR Fisk, Helena L Calder, Philip C Swan, Peter J Plank, Lindsay D World J Hepatol Randomized Clinical Trial BACKGROUND: Preoperative supplementation with immunonutrients, including arginine and n-3 fatty acids, has been shown in a number of systematic reviews to reduce infectious complications in patients who have undergone gastrointestinal surgery. Limited information, however, is available on the benefits of nutritional supplementation enriched with arginine and n-3 fatty acids in patients undergoing liver resection. AIM: To evaluate the effects of preoperative nutritional supplementation enriched with arginine and n-3 fatty acids on inflammatory and immunologic markers and clinical outcome in patients undergoing liver resection. METHODS: Thirty-four patients undergoing liver resection were randomized to either five days of preoperative Impact(®) [1020 kcal/d, immunonutrition (IMN) group], or standard care [no supplementation, standard care (STD) group]. Nutritional status was measured at study entry by subjective global assessment (SGA). Functional assessments (grip strength, fatigue and performance status) were carried out at study entry, on the day prior to surgery, and on postoperative day (POD) 7 and 30. Inflammatory and immune markers were measured at study entry, on the day prior to surgery, and POD 1, 3, 5, 7, 10 and 30. Postoperative complications were recorded prospectively until POD30. RESULTS: A total of 32 patients (17 IMN and 15 STD) were analysed. All except four patients were SGA class A. The plasma ratio of (eicosapentaenoic acid plus docosahexaenoic acid) to arachidonic acid was higher in IMN patients on the day prior to surgery and POD 1, 3, 5 and 7 (P < 0.05). Plasma interleukin (IL)-6 concentrations were elevated in the IMN group (P = 0.017 for POD7). No treatment effect was detected for functional measures, immune response (white cell count and total lymphocytes) or markers of inflammation (C-reactive protein, tumour necrosis factor-α, IL-8, IL-10). There were 10 patients with infectious complications in the IMN group and 4 in the STD group (P = 0.087). Median hospital stay was 9 (range 4–49) d in the IMN group and 8 (3-34) d in the STD group (P = 0.476). CONCLUSION: In well-nourished patients undergoing elective liver resection, this study failed to show any benefit of preoperative immunonutrition. Baishideng Publishing Group Inc 2019-03-27 2019-03-27 /pmc/articles/PMC6447421/ /pubmed/30967908 http://dx.doi.org/10.4254/wjh.v11.i3.305 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Randomized Clinical Trial
Russell, Kylie
Zhang, Han-Guang
Gillanders, Lyn K
Bartlett, Adam SJR
Fisk, Helena L
Calder, Philip C
Swan, Peter J
Plank, Lindsay D
Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial
title Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial
title_full Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial
title_fullStr Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial
title_full_unstemmed Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial
title_short Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial
title_sort preoperative immunonutrition in patients undergoing liver resection: a prospective randomized trial
topic Randomized Clinical Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447421/
https://www.ncbi.nlm.nih.gov/pubmed/30967908
http://dx.doi.org/10.4254/wjh.v11.i3.305
work_keys_str_mv AT russellkylie preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial
AT zhanghanguang preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial
AT gillanderslynk preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial
AT bartlettadamsjr preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial
AT fiskhelenal preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial
AT calderphilipc preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial
AT swanpeterj preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial
AT planklindsayd preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial